Electric zaps to the heart: a new hope for stubborn AF?
NCT ID NCT06128174
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a device called the Farawave catheter, which uses electrical pulses to destroy heart tissue causing long-standing atrial fibrillation. Twenty adults with this condition for over a year will undergo the procedure. The goal is to see if it stops abnormal heart rhythms for at least a year.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Farawave PFA catheter (device that uses electrical energy to destroy heart tissue causing abnormal signals)
- What this could lead to
- If successful, this could offer a new, safer way to control long-standing atrial fibrillation and reduce the need for lifelong medication.
- What could go wrong
- This is a small pilot study with only 20 participants, so results may not apply to everyone. The procedure carries risks like bleeding, infection, or heart damage.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LONG-STANDING PERSISTENT AF are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Mount Sinai Hospital
New York, New York, 10029, United States